Originally published by our sister publication Anesthesiology News
PHILADELPHIA—Sugammadex at a dose of 2 mg/kg is superior to neostigmine in reversing moderate neuromuscular blockade in neonates and infants younger than 2 years of age, a new study has concluded. The trial also found that doses of both 2 and 4 mg/kg were well tolerated in this sometimes fragile patient population.
“Although sugammadex has been shown to be safe and effective in reversing rocuronium- and